Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proviral DNA as a Target for HIV-1 Resistance Analysis.

Intervirology - 1 Jan 2015

Lübke Nadine, Di Cristanziano Veronica, Sierra Saleta, Knops Elena, Schülter Eugen, Jensen Björn, Oette Mark, Lengauer Thomas, Kaiser Rolf

Abstract excerpt

BACKGROUND: Resistance analysis from viral RNA is restricted to detectable viral load. Therefore, analysis from proviral DNA could help in cases with low-level or suppressed viremia. METHODS: Viral plasma RNA and the corresponding cellular proviral DNA of 78 EDTA samples from 48 therapy-naïve (TN) and 30 therapy-experienced (TE) HIV-1-infected patients were isolated and analyzed for their resistance profiles in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Viral

Share to Drug Resistance, Viral

Share to Proviruses

Share to RNA-Directed DNA Polymerase

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 26139571
DOI: 10.1159/000431093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proviral DNA as a Target for HIV-1 Resistance Analysis.PMID 26139571Read ↗

HIV-1 proviral resistance mutations: usefulness in clinical practice.Semantic proximity Read ↗

New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.Semantic proximity Read ↗

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.Semantic proximity Read ↗

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug ResistanceSemantic proximity Read ↗

Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia.Semantic proximity Read ↗

Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV.Semantic proximity Read ↗

Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.Semantic proximity Read ↗

HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.Semantic proximity Read ↗

HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA TestingSemantic proximity Read ↗

Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.Semantic proximity Read ↗

Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.Semantic proximity Read ↗

Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.